October 26, 2021 Allergy/Immunology Availability of monoclonal antibody treatment for mild to moderate COVID is limited in Canada based on medication supply and availability of dedicated infusion centres and staff in some parts of the country.
October 20, 2021 Epidemiology Public Health officials concerned about upcoming flu season in relation to concurrent risks of COVID especially for at-risk populations. #VaccinesWork #ProtectYourCommunity #ProtectYourFamily
October 14, 2021 Emergency Medicine CHEO ER treating wave of young patients in numbers usually seen in November.
August 20, 2021 Epidemiology As the SARS-CoV-2 variants continue to evolve, how will they change the pandemic? Detailed article in Science provides some of the details. https://bit.ly/37WKBtK
August 16, 2021 Health Policy The Atlantic explains how the Delta variant is affecting children in the US especially in areas with low vaccination rates. There is understandable trepidation for unvaccinated Canadian children returning to school.
August 9, 2021 Clinical Research In vitro cell-culture study demonstrates that fenofibrate (used as adjunct to statins to lower cholesterol and lipid levels) reduces severity of coronavirus infection. Human trials to follow to determine if this holds true in vivo. #GoScience
August 6, 2021 Allergy/Immunology Retrospective study finds that the flu vaccine has benefits against severe effects of COVID-19. How it does this remains unknown but if true, it will be fascinating and enlightening to figure out how our immune response works in this setting.
August 5, 2021 Clinical Research Heparin seems to reduce progression of COVID-19 in hospitalized people with moderate symptoms but not for the critically ill. Study author states that more research required to find the therapeutic “sweet spot”.
August 4, 2021 Epidemiology Imperial College London study provides more evidence that a double-vaccinated person is engaging in a classic and time-honoured risk-and-harm-reduction strategy. #vaccineswork
August 3, 2021 Epidemiology UK scientists’ early theoretical research forewarns of another coronavirus variant to come that will “lead to current vaccine failure.”